Immuno Oncology Assays Market Trends Driving Personalized Cancer
The rise in cancer incidence, coupled with rapid advancements in technology—particularly in molecular techniques—has the potential to significantly boost the immuno-oncology assays market. According to the World Health Organization (WHO), cancer is responsible for an alarming 8.8 million deaths globally, making it a leading cause of mortality. Notably, one in every six deaths is attributable to cancer, underscoring the urgent need for effective cancer management strategies.